Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder.
about
Does fesoterodine have a role in the treatment of poorly managed patients with overactive bladder?Tolterodine extended release in the treatment of male OAB/storage LUTS: a systematic review.Comparison of solifenacin and fesoterodine in treatment of overactive bladder.Urinary incontinence in men: current and developing therapy options.Patient-reported outcomes with the β3 -adrenoceptor agonist mirabegron in a phase III trial in patients with overactive bladder.Functional urology in the BJUI.Best practice in the management of storage symptoms in male lower urinary tract symptoms: a review of the evidence base.
P2860
Q27000698-6BB718FB-6556-4F70-B59F-9A9FE35EA876Q34502903-E04DD65D-9B97-4DAC-AED7-DC6BDCE28EFCQ36210264-9AFB93F7-8041-4AEA-B4E5-FA78AD0261BBQ38708104-45A8E7AF-B4CA-4B37-B3FB-39FE523C75FFQ40627462-85FB7633-27C9-431D-8142-73C26CE6B0C6Q44406361-2CF75CFB-3C7B-4E7E-94C5-E11BA14DDDD6Q50054306-99AFBC71-A11F-4974-B681-EE03EA0114B9
P2860
Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Efficacy of fesoterodine compa ...... women with overactive bladder.
@en
Efficacy of fesoterodine compa ...... women with overactive bladder.
@nl
type
label
Efficacy of fesoterodine compa ...... women with overactive bladder.
@en
Efficacy of fesoterodine compa ...... women with overactive bladder.
@nl
prefLabel
Efficacy of fesoterodine compa ...... women with overactive bladder.
@en
Efficacy of fesoterodine compa ...... women with overactive bladder.
@nl
P2093
P2860
P356
P1433
P1476
Efficacy of fesoterodine compa ...... women with overactive bladder.
@en
P2093
Con Kelleher
Dana Creanga
David Ginsberg
Diane L Martire
Philip Van Kerrebroeck
Steven Swift
Tim Schneider
P2860
P304
P356
10.1111/BJU.12174
P577
2013-08-01T00:00:00Z